| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
CGP 53820 manufacturers
- Cgp 53820
-
- $1980.00
-
2026-07-27
- CAS:149267-24-3
- Purity:
- Supply Ability: 10g
|
| | CGP 53820 Basic information |
| Product Name: | CGP 53820 | | Synonyms: | CGP 53820;(2S)-2-acetamido-N-[(2S,3S)-4-[[[(2S)-2-acetamido-3-methylbutanoyl]amino]-(cyclohexylmethyl)amino]-3-hydroxy-1-phenylbutan-2-yl]-3-methylbutanamide;L-Valine, N-acetyl-, 2-[(2S,3S)-3-[[(2S)-2-(acetylamino)-3-methyl-1-oxobutyl]amino]-2-hydroxy-4-phenylbutyl]-2-(cyclohexylmethyl)hydrazide | | CAS: | 149267-24-3 | | MF: | C31H51N5O5 | | MW: | 573.77 | | EINECS: | | | Product Categories: | | | Mol File: | 149267-24-3.mol |  |
| | CGP 53820 Chemical Properties |
| | CGP 53820 Usage And Synthesis |
| Description | Cgp 53820 is a pseudosymmetric inhibitor of HIV-1 Protease. | | Uses | CGP 53820 is an inhibitor for HIV protease, inhibits the complex of HIV-1 and HIV-2 protease with Ki of 9 and 53 nM for HIV-1 protease and HIV-2 protease. CGP 53820 can be used in AIDS research[1]. | | References | [1] Priestle JP, et al., Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor. Structure. 1995 Apr 15;3(4):381-9. DOI:10.1016/s0969-2126(01)00169-1 |
| | CGP 53820 Preparation Products And Raw materials |
|